HomeETON • NASDAQ
add
Eton Pharmaceuticals Inc
Previous close
$16.49
Day range
$15.51 - $17.11
Year range
$3.18 - $18.41
Market cap
451.88M USD
Avg Volume
255.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 11.65M | 59.26% |
Operating expense | 5.43M | -3.40% |
Net income | -598.00K | 73.49% |
Net profit margin | -5.13 | 83.37% |
Earnings per share | -0.03 | 66.67% |
EBITDA | 1.33M | 176.60% |
Effective tax rate | -17.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.94M | -30.17% |
Total assets | 76.12M | 139.83% |
Total liabilities | 51.70M | 217.87% |
Total equity | 24.43M | — |
Shares outstanding | 26.82M | — |
Price to book | 18.12 | — |
Return on assets | 4.66% | — |
Return on capital | 6.99% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -598.00K | 73.49% |
Cash from operations | -765.00K | -297.67% |
Cash from investing | -38.13M | -4,820.26% |
Cash from financing | 33.57M | 11,519.05% |
Net change in cash | -5.32M | -680.79% |
Free cash flow | -18.45M | -3,696.42% |
About
Founded
2017
Website
Employees
31
